Clinical Trial Update: Midostaurin and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating midostaurin plus decitabine in older adults with newly diagnosed AML and FLT3 mutation; study status terminated with posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Acute Myeloid Leukemia with Flt3 Mutation

Drugs mentioned

• Decitabine (Decitabine)
• Midostaurin (midostaurin)

Snippet

Sponsor: Mayo Clinic | Conditions: Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations | Phase 2 | Status: TERMINATED | Results posted: 2019-08-07